Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
576
DELISTED
Hologic
HOLX
| $41.3M | 0.04% |
818,068
+528,750
| +183% | +$26M |
|
577
Southside Bancshares
SBSI
$984M
| $41.2M | 0.03% |
1,208,810
-23,300
| -2% | -$774K |
|
578
Lantheus
LNTH
$6.59B
| $41M | 0.03% |
1,635,900
-148,400
| -8% | -$3.65M |
|
579
Bank of Hawaii
BOH
$3.15B
| $41M | 0.03% |
477,000
+15,800
| +3% | +$1.31M |
|
580
ATN International
ATNI
$491M
| $40.9M | 0.03% |
700,500
+16,200
| +2% | +$928K |
|
581
CarMax
KMX
$8.52B
| $40.9M | 0.03% |
+464,200
| New | +$39.8M |
|
582
NMI Holdings
NMIH
$3.42B
| $40.4M | 0.03% |
1,538,253
-200,847
| -12% | -$5.49M |
|
583
RE/MAX Holdings
RMAX
$265M
| $40.3M | 0.03% |
1,254,400
-600
| -0% | -$17K |
|
|
ENIA
584
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $40.1M | 0.03% |
4,402,300
+901,400
| +26% | +$7.59M |
|
|
GRMN
585
Garmin
GRMN
$60.2B
| $40M | 0.03% |
472,007
+89,565
| +23% | +$7.23M |
|
586
Medpace
MEDP
$16.2B
| $39.8M | 0.03% |
473,988
+130,888
| +38% | +$9.89M |
|
587
Enanta Pharmaceuticals
ENTA
$391M
| $39.8M | 0.03% |
662,900
+112,600
| +20% | +$8.36M |
|
588
Adient
ADNT
$1.54B
| $39.8M | 0.03% |
1,732,800
+302,100
| +21% | +$6.89M |
|
589
New Jersey Resources
NJR
$5.64B
| $39.6M | 0.03% |
875,301
-89,000
| -9% | -$4.17M |
|
590
Dell
DELL
$320B
| $39.5M | 0.03% |
1,503,909
-4,129,687
| -73% | -$109M |
|
591
America Movil
AMX
$69.8B
| $39.5M | 0.03% |
2,655,970
+1,108,996
| +72% | +$15.9M |
|
|
MGLN
592
DELISTED
Magellan Health Services, Inc.
MGLN
| $39.4M | 0.03% |
633,799
+56,400
| +10% | +$3.76M |
|
593
Par Pacific Holdings
PARR
$4.12B
| $39.2M | 0.03% |
1,714,600
+349,300
| +26% | +$7.73M |
|
594
ScottsMiracle-Gro
SMG
$3.59B
| $39.2M | 0.03% |
384,900
+283,100
| +278% | +$29.6M |
|
595
Moody's
MCO
$84.6B
| $39.1M | 0.03% |
+191,000
| New | +$40M |
|
596
Exponent
EXPO
$3.24B
| $39M | 0.03% |
557,900
-29,700
| -5% | -$2M |
|
597
DigitalBridge
DBRG
$2.94B
| $39M | 0.03% |
1,618,830
+606,002
| +60% | +$12.5M |
|
|
EBSB
598
DELISTED
Meridian Bancorp, Inc.
EBSB
| $38.9M | 0.03% |
2,077,044
+52,600
| +3% | +$958K |
|
599
Radware
RDWR
$1.25B
| $38.3M | 0.03% |
1,580,100
+176,000
| +13% | +$4.4M |
|
600
Ultrapar
UGP
$6.55B
| $38.3M | 0.03% |
8,575,280
+413,180
| +5% | +$1.95M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.